This is an important conceptual point, since in addition to the inactivation of the pRB pathway, a cancer cell acquires mutations in multiple tumor suppressors and oncogenes; and the collective outcome of these alterations eventually determines the malignancy of the cancer cell [7]. This evidence concerns the gene RB1 and neoplasm.